ES523682A0 - Un procedimiento para preparar compuestos de cefalosporina. - Google Patents
Un procedimiento para preparar compuestos de cefalosporina.Info
- Publication number
- ES523682A0 ES523682A0 ES523682A ES523682A ES523682A0 ES 523682 A0 ES523682 A0 ES 523682A0 ES 523682 A ES523682 A ES 523682A ES 523682 A ES523682 A ES 523682A ES 523682 A0 ES523682 A0 ES 523682A0
- Authority
- ES
- Spain
- Prior art keywords
- procedure
- cephalosporin compounds
- preparing cephalosporin
- preparing
- compounds
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D277/00—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings
- C07D277/02—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings
- C07D277/20—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
- C07D277/587—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with aliphatic hydrocarbon radicals substituted by carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms, said aliphatic radicals being substituted in the alpha-position to the ring by a hetero atom, e.g. with m >= 0, Z being a singly or a doubly bound hetero atom
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Cephalosporin Compounds (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| GB8218874 | 1982-06-30 | ||
| GB8222236 | 1982-08-02 |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| ES8500957A1 ES8500957A1 (es) | 1984-11-01 |
| ES523682A0 true ES523682A0 (es) | 1984-11-01 |
Family
ID=26283232
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| ES523682A Granted ES523682A0 (es) | 1982-06-30 | 1983-06-29 | Un procedimiento para preparar compuestos de cefalosporina. |
Country Status (16)
| Country | Link |
|---|---|
| US (1) | US4560683A (OSRAM) |
| EP (1) | EP0098161A3 (OSRAM) |
| AU (2) | AU1637983A (OSRAM) |
| DE (1) | DE3323462A1 (OSRAM) |
| DK (1) | DK299083A (OSRAM) |
| ES (1) | ES523682A0 (OSRAM) |
| FI (1) | FI832385L (OSRAM) |
| FR (1) | FR2529555A1 (OSRAM) |
| GB (1) | GB2123414B (OSRAM) |
| GR (1) | GR77529B (OSRAM) |
| IT (1) | IT1212876B (OSRAM) |
| LU (1) | LU84887A1 (OSRAM) |
| NL (1) | NL8302309A (OSRAM) |
| NO (1) | NO832376L (OSRAM) |
| PT (1) | PT76960B (OSRAM) |
| SE (1) | SE8303727L (OSRAM) |
Families Citing this family (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| IL68992A (en) * | 1982-06-29 | 1991-06-10 | Astra Laekemedel Ab | Alpha-bromo diethyl carbonate and process for the preparation of ethoxycarbonyloxy esters of penicillanic acids |
| DE3348300C2 (de) * | 1982-06-29 | 1994-04-21 | Astra Laekemedel Ab | Verwendung von alpha-Bromdiethylcarbonat |
| EP0148004A3 (en) * | 1983-12-30 | 1986-04-23 | Glaxo Group Limited | Cephalosporin antibiotics |
| GB8504072D0 (en) * | 1985-02-18 | 1985-03-20 | Fujisawa Pharmaceutical Co | Cephem compounds |
Family Cites Families (13)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US3966717A (en) * | 1971-05-14 | 1976-06-29 | Glaxo Laboratories Limited | 7-β-Acylamido-3-carbamoyloxymethylceph-3-em-4-carboxylic acids and salts thereof |
| US4033950A (en) * | 1971-05-14 | 1977-07-05 | Glaxo Laboratories Limited | 3-Hydroxymethyl-7β-(2-alkoxy-or benzyloxyimino-2-arylacetamido)ceph-3-em-4-carboxylic acids and salts thereof |
| US4162360A (en) * | 1973-12-21 | 1979-07-24 | Glaxo Laboratories Limited | 3-Carbamoyloxymethyl-7-substituted oximino acetamido cephalosporanic acid derivatives |
| US3946002A (en) * | 1974-07-11 | 1976-03-23 | Lilly Industries Limited | Process for preparing cephalosporins |
| DK154939C (da) * | 1974-12-19 | 1989-06-12 | Takeda Chemical Industries Ltd | Analogifremgangsmaade til fremstilling af thiazolylacetamido-cephemforbindelser eller farmaceutisk acceptable salte eller estere deraf |
| US4166115A (en) * | 1976-04-12 | 1979-08-28 | Fujisawa Pharmaceutical Co., Ltd. | Syn 7-oxoimino substituted derivatives of cephalosporanic acid |
| DE2715385A1 (de) * | 1976-04-14 | 1977-11-10 | Takeda Chemical Industries Ltd | Cephalosporinderivate, verfahren zu ihrer herstellung und sie enthaltende arzneimittel |
| FR2361895A1 (fr) * | 1976-08-20 | 1978-03-17 | Roussel Uclaf | Nouvelles oximes derivees de l'acide 3-carbamoyloxymethyl 7-amino thiazolyl acetamido cephalosporanique, leur procede de preparation et leur application comme medicaments |
| DE2714880A1 (de) * | 1977-04-02 | 1978-10-26 | Hoechst Ag | Cephemderivate und verfahren zu ihrer herstellung |
| DE2716677C2 (de) * | 1977-04-15 | 1985-10-10 | Hoechst Ag, 6230 Frankfurt | Cephemderivate und Verfahren zu ihrer Herstellung |
| GB2029824B (en) * | 1978-05-26 | 1983-02-16 | Glaxo Group Ltd | 7-oximino-2-amino-4-thiazolyl acetamido cephens |
| EP0088454B1 (en) * | 1979-09-03 | 1986-03-05 | Fujisawa Pharmaceutical Co., Ltd. | New starting compounds for preparing cephem compounds and processes for their preparation |
| EP0037797A3 (de) * | 1980-03-11 | 1981-12-16 | Ciba-Geigy Ag | Cephalosporinverbindungen, Verfahren zu ihrer Herstellung, sie enthaltende pharmazeutische Zusammensetzungen und ihre Verwendung |
-
1983
- 1983-06-29 AU AU16379/83A patent/AU1637983A/en not_active Abandoned
- 1983-06-29 NO NO832376A patent/NO832376L/no unknown
- 1983-06-29 DK DK299083A patent/DK299083A/da not_active Application Discontinuation
- 1983-06-29 AU AU16381/83A patent/AU1638183A/en not_active Abandoned
- 1983-06-29 LU LU84887A patent/LU84887A1/fr unknown
- 1983-06-29 FR FR8310796A patent/FR2529555A1/fr active Pending
- 1983-06-29 DE DE19833323462 patent/DE3323462A1/de not_active Withdrawn
- 1983-06-29 FI FI832385A patent/FI832385L/fi not_active Application Discontinuation
- 1983-06-29 ES ES523682A patent/ES523682A0/es active Granted
- 1983-06-29 GB GB08317617A patent/GB2123414B/en not_active Expired
- 1983-06-29 NL NL8302309A patent/NL8302309A/nl not_active Application Discontinuation
- 1983-06-29 GR GR71809A patent/GR77529B/el unknown
- 1983-06-29 US US06/509,043 patent/US4560683A/en not_active Expired - Fee Related
- 1983-06-29 SE SE8303727A patent/SE8303727L/xx not_active Application Discontinuation
- 1983-06-29 PT PT76960A patent/PT76960B/pt unknown
- 1983-06-29 EP EP83303758A patent/EP0098161A3/en not_active Withdrawn
- 1983-06-29 IT IT8348598A patent/IT1212876B/it active
Also Published As
| Publication number | Publication date |
|---|---|
| FI832385A7 (fi) | 1983-12-31 |
| FR2529555A1 (fr) | 1984-01-06 |
| IT1212876B (it) | 1989-11-30 |
| SE8303727D0 (sv) | 1983-06-29 |
| PT76960A (en) | 1983-07-01 |
| FI832385A0 (fi) | 1983-06-29 |
| GR77529B (OSRAM) | 1984-09-24 |
| GB2123414A (en) | 1984-02-01 |
| LU84887A1 (fr) | 1984-03-07 |
| GB2123414B (en) | 1985-12-04 |
| IT8348598A0 (it) | 1983-06-29 |
| AU1638183A (en) | 1984-01-05 |
| EP0098161A3 (en) | 1985-04-24 |
| ES8500957A1 (es) | 1984-11-01 |
| GB8317617D0 (en) | 1983-08-03 |
| NO832376L (no) | 1984-01-02 |
| DE3323462A1 (de) | 1984-01-12 |
| SE8303727L (sv) | 1984-02-03 |
| PT76960B (en) | 1986-01-24 |
| NL8302309A (nl) | 1984-01-16 |
| US4560683A (en) | 1985-12-24 |
| AU1637983A (en) | 1984-01-05 |
| DK299083D0 (da) | 1983-06-29 |
| EP0098161A2 (en) | 1984-01-11 |
| FI832385L (fi) | 1983-12-31 |
| DK299083A (da) | 1983-12-31 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| ES521153A0 (es) | Un procedimiento para preparar compuestos de quinolona. | |
| ES520983A0 (es) | Un procedimiento para preparacion de nuevos derivados de cefalosporina. | |
| ES534202A0 (es) | Un procedimiento para preparar nuevos compuestos de cefem. | |
| ES530024A0 (es) | Un procedimiento para preparar derivados de pirazinona | |
| ES521318A0 (es) | Un procedimiento para la preparacion de compuestos de bencimidazol. | |
| ES513296A0 (es) | Un procedimiento para preparar nuevos compuestos de cefem. | |
| ES528304A0 (es) | Un procedimiento para preparar derivados de pirimidona | |
| ES534297A0 (es) | Un procedimiento para preparar derivados de cefem | |
| ES520364A0 (es) | Un procedimiento para preparar compuestos de cefem. | |
| ES520224A0 (es) | Un procedimiento para la preparacion de nuevos derivados de cefalosporina. | |
| ES522403A0 (es) | Un procedimiento para la preparacion de nuevos compuestos derivados de aziridina. | |
| ES521047A0 (es) | Un procedimiento para preparar compuestos de cefem. | |
| ES518758A0 (es) | Un procedimiento para preparar azetidinas. | |
| ES521955A0 (es) | Un procedimiento para preparar derivados de cefalosporina. | |
| ES519936A0 (es) | Un procedimiento para preparar derivados de pirimidona. | |
| ES520826A0 (es) | Un procedimiento para obtener compuestos de ribofuranosilselenazol-4-carboxamida. | |
| ES524772A0 (es) | Un procedimiento para preparar fenilanilinas-n.sustituidas. | |
| ES522716A0 (es) | Un procedimiento para preparar un derivado de pirazol. | |
| ES523682A0 (es) | Un procedimiento para preparar compuestos de cefalosporina. | |
| ES526177A0 (es) | Un procedimiento para preparar derivados de pirimidona | |
| ES542958A0 (es) | Un procedimiento para preparar compuestos de cefalosporina | |
| ES527738A0 (es) | Un procedimiento para preparar derivados de piridona | |
| ES525647A0 (es) | Un procedimiento para preparar compuestos de benzoilurea | |
| ES523681A0 (es) | Un procedimiento para preparar compuestos de cefalosporina. | |
| ES520370A0 (es) | Un procedimiento para obtener derivados de isoxazolopirimidina. |